thromboxanes has been researched along with dipyridamole in 41 studies
Studies (thromboxanes) | Trials (thromboxanes) | Recent Studies (post-2010) (thromboxanes) | Studies (dipyridamole) | Trials (dipyridamole) | Recent Studies (post-2010) (dipyridamole) |
---|---|---|---|---|---|
3,202 | 149 | 199 | 7,826 | 881 | 632 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 38 (92.68) | 18.7374 |
1990's | 1 (2.44) | 18.2507 |
2000's | 2 (4.88) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahnfelt-Rønne, I; Arrigoni-Martelli, E | 1 |
McGiff, JC | 1 |
Ally, AI; Cunnane, SC; Ghayur, T; Horrobin, DF; Karmali, RA; Karmazyn, M; Manku, MS; Morgan, RO; Oka, M | 1 |
Bianchine, JR; Greenwald, JE; Panganamala, RV; Rao, M; Wong, LK | 1 |
Horrobin, DF | 1 |
Khimenko, PL | 1 |
Frishman, WH; Miller, KP | 1 |
Matsuda, T | 1 |
Lane, I; McCollum, C; Meek, A; Poskitt, K | 1 |
Boddi, M; Castellani, S; Fanara, F; Gensini, GF; Neri Serneri, GG; Pezza, A; Prisco, D; Rogasi, PG; Rostagno, C | 1 |
Lüthy, C; Odavic, R; Oetliker, O; Siegrist, M | 1 |
Lecompte, T; Samama, M | 1 |
Eisert, WG; Eldor, A; Fuks, Z; Muller, TH; Vlodavsky, I | 1 |
Christakis, GT; Henderson, MJ; Ivanov, J; Johnston, LG; Madonik, MM; Mee, AV; Mullen, JC; Teoh, KH; Warbick-Cerone, A; Weisel, RD | 1 |
Blasevich, M; Borghi, A; Galli, C; Petroni, A; Socini, A | 1 |
Stuart, MJ | 1 |
Cauchie, C | 1 |
Gurewich, V; Louie, S | 1 |
Inoue, T | 1 |
Mustard, JF; Packham, MA | 1 |
Block, LH; Rhyner, K; Stenger, M | 1 |
Lewis, GP; Smith, JR | 1 |
Imai, S; Katano, Y | 1 |
Bakhle, YS; Patel, K | 1 |
Salokannel, J; Viinikka, L; Ylikorkala, O | 1 |
Karpen, CW; Merola, AJ; Panganamala, RV; Pritchard, KA | 1 |
Hay, D; Mehta, J; Mehta, P | 1 |
Mehta, J; Mehta, P | 1 |
Förster, W | 1 |
Viinikka, L; Ylikorkala, O | 1 |
Moncada, S | 1 |
Castaldi, PA | 1 |
Verdecchia, P | 1 |
Advenier, C; Bidet, D; Floch-Saint-Aubin, A; Renier, A | 1 |
Lorenz, R; Siess, W; Weber, PC | 1 |
DelBeccaro, EJ; Heggers, JP; Robson, MC; Swaminathan, R | 1 |
Castrucci, G; Ciabattoni, G; De Salvo, A; Parachini, M; Patrono, C; Pinca, E; Pugliese, F; Satta, MA | 1 |
Dengjel, C; Frey, H | 1 |
De La Cruz, JP; García Campos, J; Mérida, F; Moreno, A; Sánchez de la Cuesta, F | 1 |
Lecompte, T | 1 |
Bhatt, DL; Meadows, TA | 1 |
9 review(s) available for thromboxanes and dipyridamole
Article | Year |
---|---|
Prostaglandins in circulatory disorders.
Topics: Angiotensin II; Antihypertensive Agents; Arachidonic Acids; Arteriosclerosis; Aspirin; Blood Platelets; Diet; Dipyridamole; Eicosanoic Acids; Humans; Hypertension; Platelet Aggregation; Prostaglandins; Thrombosis; Thromboxanes; Vascular Diseases | 1979 |
Platelets and antiplatelet therapy in ischemic heart disease.
Topics: Angina Pectoris; Angioplasty, Balloon; Arteriosclerosis; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Cyclooxygenase Inhibitors; Dipyridamole; Epoprostenol; Humans; Myocardial Infarction; Platelet Adhesiveness; Sulfinpyrazone; Thromboxanes | 1986 |
[Hypercoagulability and cerebral infarction].
Topics: Aspirin; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Cerebral Infarction; Clinical Trials as Topic; Dipyridamole; Glycoproteins; Humans; Platelet Aggregation; Sulfinpyrazone; Suloctidil; Thromboxanes; von Willebrand Factor | 1986 |
Prostaglandins and hemostasis: an overview.
Topics: Arachidonic Acid; Arachidonic Acids; Blood Platelets; Blood Vessels; Dinoprostone; Dipyridamole; Epoprostenol; Fatty Acids; Hemostasis; Humans; Lipoxygenase; Phospholipases; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Prostaglandins E; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane-A Synthase; Thromboxanes | 1983 |
Platelet adhesion.
Topics: Animals; Arachidonic Acids; Basement Membrane; Blood Coagulation; Blood Coagulation Disorders; Blood Platelets; Blood Vessels; Calcium; Cells, Cultured; Collagen; Cytoplasmic Granules; Dipyridamole; Elastin; Endothelium; Fibronectins; Humans; Magnesium; Peptide Fragments; Phagocytosis; Phosphatidylinositols; Platelet Adhesiveness; Platelet Aggregation; Prostaglandin Endoperoxides; Protein Conformation; Rabbits; Receptors, Collagen; Receptors, Immunologic; Thromboxanes; von Willebrand Factor | 1984 |
The role of prostacyclin and thromboxane A2 in the regulation of platelet behaviour.
Topics: Aspirin; Dipyridamole; Epoprostenol; Hemorrhage; Humans; Platelet Aggregation; Prostaglandins; Thrombosis; Thromboxane A2; Thromboxanes | 1980 |
[Platelets and prostaglandins in ischemic cardiopathy. Theoretical and practical aspects and research prospects].
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Coronary Disease; Dipyridamole; Humans; Platelet Aggregation; Platelet Count; Prostaglandins; Sulfinpyrazone; Thromboxanes | 1982 |
[Platelet inhibitors: old and new].
Topics: Abciximab; Antibodies, Monoclonal; Arteriosclerosis; Aspirin; Clopidogrel; Coronary Disease; Dipyridamole; Drug Monitoring; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Membrane Proteins; Patient Selection; Peptides; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Thrombosis; Thromboxanes; Ticlopidine | 2002 |
Clinical aspects of platelet inhibitors and thrombus formation.
Topics: Aspirin; Atherosclerosis; Blood Platelets; Cardiovascular Diseases; Cilostazol; Clopidogrel; Dipyridamole; Drug Resistance; Humans; Pentanoic Acids; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2 Receptor Antagonists; Pyridines; Receptor, PAR-1; Stents; Tetrazoles; Thrombosis; Thromboxanes; Ticlopidine | 2007 |
7 trial(s) available for thromboxanes and dipyridamole
Article | Year |
---|---|
Platelets and antiplatelet therapy in ischemic heart disease.
Topics: Angina Pectoris; Angioplasty, Balloon; Arteriosclerosis; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Cyclooxygenase Inhibitors; Dipyridamole; Epoprostenol; Humans; Myocardial Infarction; Platelet Adhesiveness; Sulfinpyrazone; Thromboxanes | 1986 |
[Hypercoagulability and cerebral infarction].
Topics: Aspirin; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Cerebral Infarction; Clinical Trials as Topic; Dipyridamole; Glycoproteins; Humans; Platelet Aggregation; Sulfinpyrazone; Suloctidil; Thromboxanes; von Willebrand Factor | 1986 |
A comparison of the effects of a thromboxane antagonist and cyclo-oxygenase inhibitor on platelet accumulation in arterial grafts.
Topics: Aorta; Aspirin; Biphenyl Compounds; Blood Platelets; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Dipyridamole; Femoral Artery; Humans; Thrombosis; Thromboxanes; Vascular Surgical Procedures | 1987 |
A critical appraisal of the clinical efficiency of anti-platelet drugs.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Double-Blind Method; Hemorrhage; Humans; Myocardial Revascularization; Prospective Studies; Sulfinpyrazone; Thromboxanes | 1986 |
Prevention of myocardial platelet deposition and thromboxane release with dipyridamole.
Topics: Arteries; Blood Platelets; Cardiomyopathies; Cell Count; Coronary Circulation; Dipyridamole; Humans; Leukocytes; Myocardium; Prospective Studies; Prostaglandins; Random Allocation; Thromboxanes | 1986 |
Effect of various doses of acetylsalicylic acid in combination with dipyridamole on the balance between prostacyclin and thromboxane in human serum.
Topics: Adult; Aspirin; Dipyridamole; Epoprostenol; Female; Humans; Middle Aged; Prostaglandins; Prostaglandins F, Synthetic; Thromboxanes; Time Factors | 1981 |
Anti platelet agents for strokes and myocardial infarction: a critical appraisal of recent clinical trials.
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Collagen; Coronary Disease; Dipyridamole; Evaluation Studies as Topic; Humans; Myocardial Infarction; Platelet Aggregation; Prostaglandins; Recurrence; Sulfinpyrazone; Thromboxanes | 1981 |
27 other study(ies) available for thromboxanes and dipyridamole
Article | Year |
---|---|
Rabbit lung microsomes: a rapid method for assaying simultaneously drug effects on thromboxane and prostacyclin synthesis.
Topics: Animals; Arachidonic Acids; Aspirin; Burimamide; Dipyridamole; Epoprostenol; Hydralazine; Imidazoles; Indomethacin; Lung; Microsomes; Prostaglandins; Rabbits; Thromboxanes | 1979 |
Influence of agents which modulate thromboxane A2 synthesis or action on R3230AC mammary carcinoma.
Topics: Animals; Colchicine; Copper; Diazepam; Dipyridamole; Female; Mammary Neoplasms, Experimental; Melatonin; Rats; Thromboxane A2; Thromboxanes | 1978 |
A study of three vasodilating agents as selective inhibitors of thromboxane A2 biosynthesis.
Topics: Arachidonic Acids; Blood Platelets; Diazoxide; Dipyridamole; Humans; Hydralazine; Kinetics; Male; Platelet Aggregation; Prostaglandins E; Prostaglandins F; Thromboxane A2; Thromboxanes | 1978 |
Tricyclic antidepressants, anxiety, thromboxane A2, and dipyridamole.
Topics: Antidepressive Agents, Tricyclic; Anxiety; Dipyridamole; Humans; Smoking Prevention; Thromboxane A2; Thromboxanes | 1979 |
[Effect of the complex treatment of stable stenocardia on the status of the prostacyclin-thromboxane system].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Aspirin; Dipyridamole; Drug Therapy, Combination; Epoprostenol; Humans; In Vitro Techniques; Male; Middle Aged; Nitrates; Platelet Aggregation; Thromboxanes | 1986 |
Effects of dipyridamole infusion on local platelet aggregation and local formation of thromboxane A2 in patients with pulmonary hypertension.
Topics: beta-Thromboglobulin; Dipyridamole; Female; Humans; Hypertension, Pulmonary; Lung Diseases, Obstructive; Male; Middle Aged; Platelet Aggregation; Thromboxane A2; Thromboxane B2; Thromboxanes | 1985 |
Effects of dipyridamole on prostaglandin synthesis in human fibroblasts.
Topics: 6-Ketoprostaglandin F1 alpha; Bradykinin; Cells, Cultured; Child, Preschool; Dipyridamole; Epoprostenol; Fibroblasts; Humans; Male; Prostaglandins; Stimulation, Chemical; Thromboxanes | 1987 |
Different effects of aspirin, dipyridamole and UD-CG 115 on platelet activation in a model of vascular injury: studies with extracellular matrix covered with endothelial cells.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Blood Platelets; Cattle; Cells, Cultured; Dipyridamole; Endothelium; Epoprostenol; Extracellular Matrix; Humans; Models, Biological; Platelet Aggregation; Pyridazines; Thromboxanes | 1986 |
Differential effects of various vasoactive drugs on basal and stimulated levels of TXB2 and 6-keto-PGF1 alpha in rat brain.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Brain; Dipyridamole; Male; Microwaves; Nifedipine; Papaverine; Rats; Thromboxane B2; Thromboxanes; Vasomotor System | 1985 |
[Surveillance of treatment with antiaggregating agents].
Topics: Aspirin; Blood Coagulation Tests; Dipyridamole; Epoprostenol; Humans; Platelet Aggregation; Prostaglandins; Thromboxane A2; Thromboxanes | 1983 |
The antithrombotic effect of aspirin and dipyridamole in relation to prostaglandin synthesis.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Dipyridamole; Epoprostenol; Fibrinolytic Agents; Male; Prostaglandins; Rabbits; Thrombosis; Thromboxanes | 1983 |
[Blood thromboxane A2 and prostaglandin I2 levels and platelet phospholipid fatty acid composition ratios in ischemic heart disease and cerebral infarction--with special reference to the effect of antiplatelet agents].
Topics: Aged; Aspirin; Blood Platelets; Cerebral Infarction; Coronary Disease; Dipyridamole; Epoprostenol; Fatty Acids; Female; Humans; Male; Middle Aged; Phospholipids; Thromboxane A2; Thromboxanes; Trapidil | 1983 |
[Divergence between the pharmacologic and clinical effects of inhibitors of prostaglandin synthesis].
Topics: Aspirin; Blood Platelets; Dipyridamole; Drug Interactions; Epoprostenol; Humans; Platelet Aggregation; Prostaglandin Antagonists; Prostaglandin-Endoperoxide Synthases; Salicylates; Salicylic Acid; Sulfinpyrazone; Thrombosis; Thromboxanes | 1984 |
Prostaglandin endoperoxides and thromboxane A2 in thrombus formation in the hamster cheek pouch in vivo.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Cheek; Cricetinae; Cyclooxygenase Inhibitors; Dipyridamole; Epoprostenol; Male; Mesocricetus; Microscopy, Electron; Platelet Aggregation; Sulfinpyrazone; Thrombosis; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes | 1984 |
The effects of dipyridamole on TXA2 formation by horse platelet microsomes.
Topics: Animals; Blood Platelets; Dipyridamole; Horses; Imidazoles; In Vitro Techniques; Microsomes; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Thromboxane A2; Thromboxanes; Vasodilator Agents | 1983 |
Thromboxane B2 (TxB2) metabolism in rat isolated lung and its inhibition by drugs.
Topics: Animals; Bromcresol Green; Dinoprostone; Dipyridamole; Furosemide; In Vitro Techniques; Lung; Male; Perfusion; Prostaglandins E; Rats; Rats, Inbred Strains; Thromboxane B2; Thromboxanes | 1983 |
Effect of prolonged treatment with acetylsalicylic acid and dipyridamole on platelet thromboxane A2 production in atherosclerotic subjects.
Topics: Aged; Arteriosclerosis; Aspirin; Blood Platelets; Dipyridamole; Female; Humans; Kinetics; Male; Thromboxane A2; Thromboxane B2; Thromboxanes | 1983 |
Alterations of the prostacyclin-thromboxane ratio in streptozotocin induced diabetic rats.
Topics: Animals; Aorta, Thoracic; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Diabetes Mellitus, Experimental; Dinoprostone; Dipyridamole; Epoprostenol; Male; Prostaglandins; Prostaglandins E; Rats; Rats, Inbred Strains; Thrombin; Thromboxane A2; Thromboxanes; Time Factors | 1982 |
Effect of dipyridamole on prostaglandin generation by human platelets and vessel walls.
Topics: Arachidonic Acid; Arachidonic Acids; Blood Platelets; Dipyridamole; Drug Synergism; Epoprostenol; Humans; Platelet Aggregation; Prostaglandins; Thromboxane A2; Thromboxanes; Umbilical Veins | 1982 |
Significance of platelet function and thromboxane B2 levels across the human myocardial vascular bed.
Topics: Arteriosclerosis; Aspirin; Coronary Circulation; Coronary Disease; Coronary Vessels; Dipyridamole; Humans; Platelet Aggregation; Propranolol; Tachycardia; Thromboxane B2; Thromboxanes | 1981 |
Significance of prostaglandins and thromboxane A2 for the mode of action of cardiovascular drugs.
Topics: Animals; Anti-Arrhythmia Agents; Aorta; Dipyridamole; Epoprostenol; Guinea Pigs; Heart; Humans; Hypertension; Platelet Aggregation; Prostaglandins; Rats; Regional Blood Flow; Thromboxane A2; Thromboxanes | 1980 |
Contribution of prostaglandins and thromboxanes to the adenosine and ATP-induced contraction of guinea-pig isolated trachea.
Topics: Adenosine; Adenosine Triphosphate; Animals; Dipyridamole; Guinea Pigs; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Prostaglandins; Thromboxanes; Trachea | 1982 |
Effects of very low versus standard dose acetyl salicylic acid, dipyridamole and sulfinpyrazone on platelet function and thromboxane formation in man.
Topics: Adenosine Diphosphate; Adult; Arachidonic Acids; Aspirin; Blood Platelets; Collagen; Dipyridamole; Dose-Response Relationship, Drug; Female; Humans; Male; Platelet Aggregation; Sulfinpyrazone; Thromboxane B2; Thromboxanes | 1981 |
The use of specific thromboxane inhibitors to preserve the dermal microcirculation after burning.
Topics: Animals; Burns; Dipyridamole; Female; Guinea Pigs; Heterocyclic Compounds; Imidazoles; Ischemia; Methimazole; Microcirculation; Skin; Thromboxanes | 1980 |
Radioimmunoassay of serum thromboxane B2: a simple method of assessing pharmacologic effects on platelet function.
Topics: Aspirin; Blood Coagulation; Blood Platelets; Cross Reactions; Diflunisal; Dipyridamole; Humans; Platelet Aggregation; Radioimmunoassay; Thromboxane B2; Thromboxanes | 1980 |
Effects of inhibitions of thromboxane synthesis on reactions of the cat bronchus in situ to prostaglandins.
Topics: Acetophenones; Animals; Bronchi; Bronchodilator Agents; Cats; Dipyridamole; Dose-Response Relationship, Drug; Female; Imidazoles; Male; Prostaglandins E; Prostaglandins F; Serotonin; Thromboxane A2; Thromboxanes | 1980 |
The pyrimido-pyrimidine derivatives, dipyridamole, mopidamol and RA-642, prevent from retinal vascular defects in experimental diabetes mellitus.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Dipyridamole; Epoprostenol; Male; Mopidamol; Neovascularization, Pathologic; Platelet Aggregation Inhibitors; Pyrimidines; Rats; Rats, Wistar; Thromboxanes | 1996 |